Product Information
QULIPTA 30 MG TABLET is a brand product labeled by AbbVie Inc., priced at $38.4051 per EA under NDC 00074709630. Its NADAC has been published 227 times since Feb 23, 2022.
Strength
30 mg/1
Manufacturer
AbbVie Inc.NDC
00074709630
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATOGEPANTApproval Type
New Drug (NDA)
FDA Application
NDA215206On Market Since
9/30/2021
Pharmacological Classes
Price Statistics
The NADAC for QULIPTA 30 MG TABLET has been published 227 times since Feb 23, 2022, and over the history we have for it it has risen 21.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $38.4051 per EA |
|---|---|
| All-time high | $38.4678 (Jun 10, 2026) |
| All-time low | $31.5171 (Feb 23, 2022) |
| 52-week high | $38.4678 |
| 52-week low | $36.5710 |
| Median price | $34.8630 |
| Average price | $34.5862 |
| Largest weekly change | +5.0% (Jan 10, 2024) |
| Weeks tracked | 227 |
| Tracking since | Feb 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Atogepant market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of QULIPTA 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QULIPTA 30 MG TABLET, manufactured by AbbVie Inc., is $38.4051 per EA (NDC 00074709630), effective Jun 24, 2026.
How has the price of QULIPTA 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for QULIPTA 30 MG TABLET has risen 21.9%. It has been tracked across 227 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for QULIPTA 30 MG TABLET?
Since Feb 23, 2022, the NADAC for QULIPTA 30 MG TABLET has ranged from a low of $31.5171 (Feb 23, 2022) to a high of $38.4678 (Jun 10, 2026), with a median of $34.8630 per EA.
Are there cheaper alternatives to QULIPTA 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of QULIPTA 30 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures QULIPTA 30 MG TABLET?
QULIPTA 30 MG TABLET (NDC 00074709630) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification